- Home
- BASE vs ELVN Comparison
BASE vs ELVN Comparison
Compare BASE & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BASE
- ELVN
- Stock Information
- Founded
- BASE 2011
- ELVN 2016
- Country
- BASE United States
- ELVN United States
- Employees
- BASE N/A
- ELVN N/A
- Industry
- BASE EDP Services
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- BASE Technology
- ELVN Health Care
- Exchange
- BASE Nasdaq
- ELVN Nasdaq
- Market Cap
- BASE 1.0B
- ELVN 927.8M
- IPO Year
- BASE 2021
- ELVN 2020
- Fundamental
- Price
- BASE $24.49
- ELVN $21.30
- Analyst Decision
- BASE Buy
- ELVN Strong Buy
- Analyst Count
- BASE 16
- ELVN 5
- Target Price
- BASE $22.07
- ELVN $39.60
- AVG Volume (30 Days)
- BASE 1.2M
- ELVN 594.3K
- Earning Date
- BASE 06-03-2025
- ELVN 08-12-2025
- Dividend Yield
- BASE N/A
- ELVN N/A
- EPS Growth
- BASE N/A
- ELVN N/A
- EPS
- BASE N/A
- ELVN N/A
- Revenue
- BASE $214,662,000.00
- ELVN N/A
- Revenue This Year
- BASE $12.17
- ELVN N/A
- Revenue Next Year
- BASE $14.28
- ELVN N/A
- P/E Ratio
- BASE N/A
- ELVN N/A
- Revenue Growth
- BASE 12.76
- ELVN N/A
- 52 Week Low
- BASE $12.78
- ELVN $13.30
- 52 Week High
- BASE $25.16
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- BASE 79.94
- ELVN 55.53
- Support Level
- BASE $18.89
- ELVN $18.53
- Resistance Level
- BASE $20.07
- ELVN $24.11
- Average True Range (ATR)
- BASE 0.81
- ELVN 1.96
- MACD
- BASE 0.26
- ELVN 0.15
- Stochastic Oscillator
- BASE 91.57
- ELVN 55.68
About BASE Couchbase Inc.
Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.